China Universal Asset Management Company’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$429K	Buy	33,464 +14,590	+77%	+$186K	0.03%	270
2025 Q4	$170K	Sell	18,874 -19,942	-51%	-$275K	0.01%	363
2025 Q3	$670K	Buy	38,816 +18,012	+87%	+$222K	0.06%	213
2025 Q2	$195K	Buy	20,804 +40	+0.2%	+$328	0.02%	314
2025 Q1	$148K	Sell	20,764 -832	-4%	-$8.4K	0.01%	336
2024 Q4	$252K	Buy	21,596 +2,059	+11%	+$32.1K	0.02%	310
2024 Q3	$401K	Buy	19,537 +8,204	+72%	+$189K	0.04%	239
2024 Q2	$254K	Sell	11,333 -7,141	-39%	-$170K	0.04%	211
2024 Q1	$508K	Buy	18,474 +8,119	+78%	+$226K	0.06%	179
2023 Q4	$316K	Buy	10,355 +8,092	+358%	+$233K	0.06%	170
2023 Q3	$71.6K	Buy	2,263 +1,108	+96%	+$43K	0.02%	216
2023 Q2	$47.1K	Sell	1,155 -37	-3%	-$1.5K	0.01%	200
2023 Q1	$44.4K	Buy	1,192 +238	+25%	+$9.33K	0.02%	159
2022 Q4	$33.3K	Buy	954 +88	+10%	+$4.18K	0.01%	151
2022 Q3	$48K	Buy	866 +712	+462%	+$44.2K	0.02%	123
2022 Q2	$8K	Hold	154	–	–	﹤0.01%	88
2022 Q1	$11K	Hold	154	–	–	﹤0.01%	79
2021 Q4	$18K	Buy	+154	New	+$19.3K	﹤0.01%	82